What the California Fires Mean for the Weed Industry
Articles
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Enters the Multibillion-Dollar Tea Market
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
India Globalization Capital, Inc. (NYSE: IGC) Could Release Potential Blockbuster Alzheimer’s Treatment in Early 2018
India Globalization Capital, Inc. (NYSE MKT: IGC) is on the precipice of bringing a potential blockbuster treatment for Alzheimer’s to the market.
CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Achieves 42% Month-Over-Month Revenue Growth in October
PotNetwork Holding (OTC: POTN) this morning announced that Diamond CBD, Inc., the company’s wholly owned subsidiary, reported revenues for October of nearly $1.7 million.
Investors Could Reap Global Rewards of Research into Medical Cannabis Science
Cannabis companies have ramped up their efforts to make new scientific discoveries related to the plant’s medical uses.
How Biosynthesis is Revolutionizing Cannabinoid Pharmaceuticals
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Targets Global Cannabis Market
ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
AV1 Group, Inc. (AVOP) is “One to Watch”
AV1 Group, Inc. is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies.
Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand
A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC.
Economic Impact of Biosynthesis on the Cannabis Industry
InMed Pharmaceuticals has developed a proprietary process capable of extracting all 90+ cannabinoids in a laboratory setting.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Seeks to Become A ‘Global Presence’
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States
India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex.
Merger and Acquisition Activity is Heating Up in the Cannabis Industry
Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased activity.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool.